Immunological Effects of Multikinase Inhibitors for Kidney Cancer: A Clue for Integration with Cellular Therapies?

Porta, Camillo; Paglino, Chiara; Imarisio, Ilaria; Ganini, Carlo; Pedrazzoli, Paolo

doi:10.7150/jca.2.333

International Journal of Biological Sciences

International Journal of Medical Sciences

Theranostics

Journal of Genomics

Nanotheranostics

open access Global reach, higher impact

Full Text | PDF

J Cancer 2011; 2:333-338. doi:10.7150/jca.2.333 This volume Cite

Review

Immunological Effects of Multikinase Inhibitors for Kidney Cancer: A Clue for Integration with Cellular Therapies?

Camillo Porta^{1,2 ✉}, Chiara Paglino^1,2, Ilaria Imarisio^1,2, Carlo Ganini¹, Paolo Pedrazzoli¹

1. Oncologia Medica, Fondazione I.R.C.C.S. Policlinico San Matteo, Pavia, Italy.
2. Gruppo Italiano di Oncologia Nefrologica - G.I.O.N. (Italian Nephro-Oncology Group).

Citation:

Porta C, Paglino C, Imarisio I, Ganini C, Pedrazzoli P. Immunological Effects of Multikinase Inhibitors for Kidney Cancer: A Clue for Integration with Cellular Therapies?. J Cancer 2011; 2:333-338. doi:10.7150/jca.2.333. https://www.jcancer.org/v02p0333.htm

Other styles

Abstract

The multikinase inhibitors Sunitinib and Sorafenib not only inhibit angiogenesis and tumor growth, but also have the potential of interacting with the function of the immune system.

Presently available data seem to suggest that Sorafenib may exert immune suppressive effects, whilst the effects of Sunitinib are not so clear, being immune stimulatory in the vast majority - but not all - the studies reported.

Trials of combination of these multikinase inhibitors with different types of immune manipulation - and cellular therapies in particular - should be rationally designed taking into account all these complex effects, which ultimately deserve further insights.

Keywords: immunology, kidney cancer, multikinase inhibitors, cellular therapies.

Citation styles

APA

Porta, C., Paglino, C., Imarisio, I., Ganini, C., Pedrazzoli, P. (2011). Immunological Effects of Multikinase Inhibitors for Kidney Cancer: A Clue for Integration with Cellular Therapies?. Journal of Cancer, 2, 333-338. https://doi.org/10.7150/jca.2.333.

ACS

Porta, C.; Paglino, C.; Imarisio, I.; Ganini, C.; Pedrazzoli, P. Immunological Effects of Multikinase Inhibitors for Kidney Cancer: A Clue for Integration with Cellular Therapies?. J. Cancer 2011, 2, 333-338. DOI: 10.7150/jca.2.333.

NLM

CSE

Porta C, Paglino C, Imarisio I, Ganini C, Pedrazzoli P. 2011. Immunological Effects of Multikinase Inhibitors for Kidney Cancer: A Clue for Integration with Cellular Therapies?. J Cancer. 2:333-338.

This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) License. See http://ivyspring.com/terms for full terms and conditions.